Pharmacological Topics of Bone Metabolism: Glutamate as a Signal Mediator in Bone

10.1038/342643a0 2 Yoneda Y, Kuramoto N, Kitayama T, Hinoi E. Consolidation of transient ionotropic glutamate signals through nuclear transcription factors in the brain. Prog Neurobiol. 2001;63:697–719. 10.1146/annurev.ne.17.030194.000335 1988, 33, 581 10.1016/0896-6273(92)90118-W 10.1016/0959-4388(93)90120-N 7 Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1–105. 10.1073/pnas.89.22.10955 1986, 261, 2256, 10.1016/S0021-9258(17)35926-4 10.1074/jbc.274.17.11455 10.1016/S0197-0186(00)00035-8 12 Bukowski DM, Deneke SM, Lawrence RA, Jenkinson SG. A noninducible cystine transport system in rat alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 1995;268:L21–L26. 10.1126/science.289.5481.957 10.1074/jbc.M104578200 10.1074/jbc.M206738200 10.1038/nature01658 10.1038/nature01660 10.1126/science.289.5484.1501 19 Akagawa KS, Takasuka N, Nozaki Y, Komuro I, Azuma M, Ueda M, et al. Generation of CD1+RelB+ dendritic cells and tartrate-resistant acid phosphatase-positive osteoclast-like multinucleated giant cells from human monocytes. Blood. 1996;88:4029–4039. 10.1182/blood.V98.8.2544 21 Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res. 1990;5:781–789. 10.1038/345442a0 10.1016/S0092-8674(00)81569-X 10.1073/pnas.95.7.3597 25 Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone. 1998;22:295–299. 10.1002/jcb.10463 27 Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J. 1999;13:2179–2185. 28 Gu Y, Genever PG, Skerry TM, Publicover SJ. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif Tissue Int. 2002;70:194–203. 29 Ho ML, Tsai TN, Chang JK, Shao TS, Jeng YR, Hsu C. Down-regulation of n-methyl d-aspartate receptor in rat modelled disuse osteopenia. Osteoporos Int. 2005;16:1780–1788. 10.1002/jcb.1114 31 Patton AJ, Genever PG, Birch MA, Suva LJ, Skerry TM. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. Bone. 1998;22:645–649. 32 Takarada T, Hinoi E, Kambe Y, Sahara K, Kurokawa S, Takahata Y, et al. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid. Eur J Pharmacol. 2007;575:1–11. 33 Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol. 2007;170:1277–1290. 34 Hinoi E, Fujimori S, Yoneda Y. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J. 2003;17:1532–1534. 10.1016/S0006-8993(02)02726-9 10.1006/bbrc.2001.4355 10.1016/j.bcp.2004.03.020 10.1016/S0006-291X(02)02223-4